238 related articles for article (PubMed ID: 29343147)
1. Estimation of intra-arterial chemotherapy distribution to the retina in pediatric retinoblastoma patients using quantitative digital subtraction angiography.
Kondapavulur S; Cooke DL; Kao A; Amans MR; Alexander M; Darflinger R; Dowd CF; Higashida RT; Damato B; Halbach VV; Matthay KK; Hetts SW
Interv Neuroradiol; 2018 Apr; 24(2):214-219. PubMed ID: 29343147
[TBL] [Abstract][Full Text] [Related]
2. Superselective intra-arterial chemotherapy in the primary management of advanced intra-ocular retinoblastoma: first 4-year experience from a single institution in Turkey.
Tuncer S; Sencer S; Kebudi R; Tanyıldız B; Cebeci Z; Aydın K
Acta Ophthalmol; 2016 Nov; 94(7):e644-e651. PubMed ID: 27214798
[TBL] [Abstract][Full Text] [Related]
3. Complete regression of retinoblastoma following intra-arterial chemotherapy.
Ni N; Shields CL; Bianciotto CG; Jabbour PM; Rosenwasser RH; Shields JA
J Pediatr Ophthalmol Strabismus; 2011 Jun; 48 Online():e23-5. PubMed ID: 21634361
[TBL] [Abstract][Full Text] [Related]
4. Alternative treatment for retinoblastoma: Intra-arterial chemotherapy with melphalan.
De Freytas A; Harto-Castaño M; Barranco H; Aviño J; Martinez-Costa R
Arch Soc Esp Oftalmol; 2015 Oct; 90(10):487-90. PubMed ID: 26008929
[TBL] [Abstract][Full Text] [Related]
5. Intra-arterial chemotherapy for retinoblastoma: report No. 2, treatment complications.
Shields CL; Bianciotto CG; Jabbour P; Griffin GC; Ramasubramanian A; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1407-15. PubMed ID: 21670326
[TBL] [Abstract][Full Text] [Related]
6. Two-dose exposure of intra-arterial chemotherapy for group D retinoblastoma.
Hutchinson A; Kaliki S; Shields CL
J Pediatr Ophthalmol Strabismus; 2012 Mar; 49 Online():e15-8. PubMed ID: 22443587
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of intra-arterial chemotherapy for retinoblastoma: experiences in a large single center cohort study.
Stenzel E; Göricke S; Temming P; Biewald E; Zülow S; Göbel J; Wanke I; Umutlu L; Kleinschnitz C; Bornfeld N; Forsting M; Radbruch A; Mönninghoff C
Neuroradiology; 2019 Mar; 61(3):351-357. PubMed ID: 30643921
[TBL] [Abstract][Full Text] [Related]
8. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
Bianciotto C; Shields CL; Iturralde JC; Sarici A; Jabbour P; Shields JA
Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
[TBL] [Abstract][Full Text] [Related]
9. [Analysis on the safety of ophthalmic artery cannulation for intra-arterial chemotherapy in 42 patients with intraocular stage retinoblastoma].
Liu QL; Wang YF; Mao GS; Yang XJ; Sun YF; Miao LX; Wang J; Yuan HL; Li YS; Liu HY; Wang XL; Zhao F
Zhonghua Er Ke Za Zhi; 2012 Oct; 50(10):793-7. PubMed ID: 23302573
[TBL] [Abstract][Full Text] [Related]
10. Access to the ophthalmic artery by retrograde approach through the posterior communicating artery for intra-arterial chemotherapy of retinoblastoma.
Pham CT; Blanc R; Lumbroso-Le Rouic L; Pistocchi S; Bartolini B; Piotin M
Neuroradiology; 2012 Aug; 54(8):845-8. PubMed ID: 22089977
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Technical and Adjunctive Factors with Quantitative Tumor Reduction in Children Undergoing Selective Ophthalmic Artery Infusion Chemotherapy for Retinoblastoma.
Abruzzo T; Abraham K; Karani KB; Geller JI; Vadivelu S; Racadio JM; Zhang B; Correa ZM
AJNR Am J Neuroradiol; 2021 Jan; 42(2):354-361. PubMed ID: 33361377
[TBL] [Abstract][Full Text] [Related]
12. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
Shields CL; Bianciotto CG; Jabbour P; Ramasubramanian A; Lally SE; Griffin GC; Rosenwasser R; Shields JA
Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
[TBL] [Abstract][Full Text] [Related]
13. Risk Factors for Acute Choroidal Ischemia after Intra-arterial Melphalan for Retinoblastoma: The Role of the Catheterization Approach.
Stathopoulos C; Bartolini B; Marie G; Beck-Popovic M; Saliou G; Munier FL
Ophthalmology; 2021 May; 128(5):754-764. PubMed ID: 32956742
[TBL] [Abstract][Full Text] [Related]
14. Angiographic investigation of orbital vascular variations in the rabbit and implications for endovascular intra-arterial chemotherapy models.
Froehler MT; Feldman MJ; Poitras B; Daniels AB
J Neurointerv Surg; 2021 Jun; 13(6):559-562. PubMed ID: 32917761
[TBL] [Abstract][Full Text] [Related]
15. Identification of Intraorbital Arteries in Pediatric Age by High Resolution Superselective Angiography.
Bracco S; Venturi C; Leonini S; Romano DG; Cioni S; Vallone IM; Gennari P; Galluzzi P; Hadjistilianou T; De Francesco S; Guglielmucci D; Tarantino F; Bertelli E
Orbit; 2015; 34(5):237-47. PubMed ID: 26154349
[TBL] [Abstract][Full Text] [Related]
16. Rescue intra-arterial chemotherapy following retinoblastoma recurrence after initial intra-arterial chemotherapy.
Shields CL; Say EA; Pointdujour-Lim R; Cao C; Jabbour PM; Shields JA
J Fr Ophtalmol; 2015 Jun; 38(6):542-9. PubMed ID: 25982423
[TBL] [Abstract][Full Text] [Related]
17. OPHTHALMIC VASCULAR EVENTS AFTER INTRA-ARTERIAL CHEMOTHERAPY FOR RETINOBLASTOMA: Real-World Comparison Between Primary and Secondary Treatments.
Ancona-Lezama D; Dalvin LA; Lucio-Alvarez JA; Jabbour P; Shields CL
Retina; 2019 Dec; 39(12):2264-2272. PubMed ID: 30204728
[TBL] [Abstract][Full Text] [Related]
18. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
Munier FL; Beck-Popovic M; Balmer A; Gaillard MC; Bovey E; Binaghi S
Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
[TBL] [Abstract][Full Text] [Related]
19. [Superselective intra-arterial chemotherapy with melphalan for retinoblastoma].
Padrón-Pérez N; Català-Mora J
J Fr Ophtalmol; 2014 Feb; 37(2):176. PubMed ID: 24210940
[No Abstract] [Full Text] [Related]
20. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
